M
MOLECL
Switzerland · Biotech
MOLECL develops nanopore-based instruments and software for analysing individual molecules in diagnostics research and biopharmaceutical quality control.
Product
MOLECL builds molecular analysis tools based on solid-state nanopore biosensing. Its platform combines nanofluidics, disposable flow cells and signal-analysis software to examine individual molecules and distinguish structural features or modifications.
The company targets research and quality-control work across genomics, proteins and biologic medicines. Users select cartridges and software for their application, with potential uses including sequencing sample checks, antibody characterisation and biomarker research.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| i4L Innogrant for Biotherapeutics | CHF 100K | EPFL Startup Launchpad — Participant |